Prof. Sarah Younie | Health Education Award | Best Researcher Award

Prof. Sarah Younie, ICET Chair, United Kingdom

Professor Sarah Emma Younie is a distinguished academic in the field of educational innovation, currently serving as Professor of Education Innovation at De Montfort University. With a Ph.D. in Education, Technology & Policy from De Montfort University and a range of qualifications including an MA in Sociology of Contemporary Culture from the University of York, a PGCE from the University of Leicester, and a BA (Hons) in Philosophy from the University of Warwick, Professor Younie has made significant contributions to education and technology. She is the Editor-in-Chief of the international journal Technology, Pedagogy and Education (Taylor & Francis) and serves as Series Book Editor for Routledge. Her leadership extends to roles such as Chair of the Education Futures Collaboration (EFC), international board member of ICET (International Council on Education for Teaching), and executive board member of the Technology, Pedagogy, and Education Association (TPEA). Professor Younie has been an influential member of various professional bodies, including BERA and SES, and has held notable positions such as Trustee of the EFC Charity and the TPEA Charity.

Professional Profile:

ORCID

Suitability for Best Researcher Award:

Professor Sarah Younie is a highly qualified candidate for the Best Researcher Award. Her extensive contributions to the field of educational innovation, coupled with her significant roles as Editor-in-Chief and board member of key educational organizations, demonstrate her exceptional leadership and impact. Her research, particularly in public health education and educational technology, showcases her commitment to advancing the field and improving educational practices globally. Her scholarly output, combined with her active involvement in professional bodies and contributions to educational policy, underline her suitability for this prestigious award.

Education:

PhD in Education, Technology & Policy
De Montfort University, 2007
MA in Sociology of Contemporary Culture
University of York, 1993-1994
(ESRC Award)
PG Cert in Further Professional Study in Education
University of Cambridge, 1992-1993
PGCE in English and Humanities (11-18 yrs)
University of Leicester, 1988-1989
BA (Hons) in Philosophy
University of Warwick, 1985-1988
(First Class-Distinction)

Professional Experience:

Professor of Educational Innovation
De Montfort University, 2017-present
Visiting Professor of Education
Chichester University, 2020-present
Reader in Education, Innovation, and Technology
De Montfort University, 2014-2017
Visiting Senior Research Fellow
University of Bedfordshire, 2011-2014
(REF 2014)
Principal Lecturer in Education
De Montfort University, 2001-2014
(BA, MA, PhD)
Senior Lecturer in Education
De Montfort University, 2000-2001
(BA Education Studies)
Senior Lecturer in Education
De Montfort University, 0.5 (PGCE Tutor), 1998-2000
Research Fellow in Education
De Montfort University, 0.5 (EU Research Project), 1998-2000
Lecturer in English, Media, and Cultural Studies
De Montfort University, 1997-1998
(New Media Technologies)

Publication top Notes:

“Bye-Bye Germs”: Respiratory Tract Infection Prevention—An Education Intervention for Children

The longitudinal effect of disseminating handwashing public health education to children in India via co-created, culturally relevant resources

The longitudinal effect of disseminating handwashing public health education to children in India via co-created, culturally relevant resources.

Evaluating Eye Tracking Technology for Assessment of Students with Profound and Multiple Learning Difficulties

Evaluating approaches to designing effective Co-Created hand-hygiene interventions for children in India, Sierra Leone and the UK

Dr. Amr Khalifa, University of Genoa/Department of Internal Medicine and Medical Specialties (DIMI), Italy

Dr. Amr Khalifa is a dedicated Postdoctoral Research Fellow at the University of Genoa’s Department of Internal Medicine and Medical Specialties, working in Prof. Alessio Nencioni’s lab. He completed his Ph.D. in Hemato-oncology and Clinical-Translational Internal Medicine at the same institution in 2022, following a Master’s in Biotechnology from Alexandria University and a Bachelor’s in Pharmacy from Pharos University. With a decade of professional experience, Dr. Khalifa has contributed to the field through his roles as an Assistant Lecturer, Community Pharmacist, and active researcher. His technical skills include advanced analytical methods, scientific writing, and effective communication of research findings. He has presented his work at major conferences and completed various specialized courses. Dr. Khalifa’s achievements include prestigious fellowships, notable awards, and significant roles in grant preparations. His engagement extends to several professional societies and community service through charity organizations.

Education & Research Experience

📚 Ph.D. in Hemato-Oncology (University of Genoa, Italy)
📚 M.Sc. in Biotechnology (Alexandria University, Egypt)
📚 BPharm (Pharos University in Alexandria, Egypt)

Dr. Khalifa has extensive experience in biotechnology and pharmacy, with a keen interest in cancer research. His doctoral research explored innovative approaches in cancer treatment, particularly the synergistic antitumor activities of periodic fasting and cholesterol biosynthesis inhibitors in gastrointestinal cancers. 🧪

Publication top Notes:

Advances in Diet and Physical Activity in Breast Cancer Prevention and Treatment

Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity

Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity

Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery

Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer.

Safety and Feasibility of Fasting-Mimicking Diet and Effects on Nutritional Status and Circulating Metabolic and Inflammatory Factors in Cancer Patients Undergoing Active Treatment